While general trends indicated that the NUC-treated group had lower risk of PD than the untreated group across all subgroups, these differences did not reach statistical significance.
← all excerpts
Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients.
1
—
—